Allergy experts

Professor Stephen Durham

StephenDurham
Professor Stephen Durham is Head of the Allergy and Clinical Immunology Section at National Heart and Lung Institute, Imperial College London and Honorary Consultant Physician in Allergy and Respiratory Medicine at Royal Brompton Hospital London. He has studied the basic mechanisms of allergic rhinitis and asthma and has a particular focus on translational studies of allergen immunotherapy.

Professor Mohamed Shamji

Mohamed Shamji

Dr. Shamji completed his clinical scientist fellowship training in clinical immunology at the Chelsea & Westminster Hospital NHS Foundation Trust in London, United Kingdom (UK) in 2004. He then pursued his interest in translational research and completed my PhD studies in allergy and clinical immunology at the National Heart & Lung Institute, Imperial College London, UK in 2010. He has recently established his research group (Immunomodulation and Tolerance group) within Allergy and Clinical Immunology at Imperial College lead by Professor Stephen Durham.

He is an American Academy Asthma Allergy and Immunology (AAAAI) international Fellow since 2014 and a committee member for Immunotherapy, Allergen Standardization and Allergy Diagnostic interest section (IASAD) (since 2011) and Immunotherapy, Rhinitis, Sinusitis, Ocular allergy and Cough (IRSOC) (since 2015). He represents basic science at the British Society of Allergy and Clinical Immunology (BSACI) annual meeting programme planning committee.

 

Professor Ralph Mösges

RalphMosges
Ralph Mösges, FAAAAI (MD, PhD, MSc Electrical Engineering) is an otorhinolaryngologist and allergist and since 1996 has been Professor for Medical Informatics and Deputy Chairman of the Institute of Medical Statistics, Informatics and Epidemiology at the University of Cologne in Germany.
He was previously an otorhinolaryngology consultant responsible for the ORL Allergy Clinic at the University Hospital, Medical Faculty of Aachen, where he is currently a lecturer in otorhinolaryngology.
Following the completion of medical and engineering studies at the Universities of Aachen and Munich in Germany, Ralph Mösges received specialist training in otorhinolaryngology and received advanced degrees in otorhinolaryngology, allergology and he holds a PhD degree in medical informatics.
In 1986 he was a fellow in clinical pharmacology at the WHO co-operative centre LERS in Paris and Munich and later served as a consultant for this scientific institution.
His current major research fields are allergology, epidemiology and clinical pharmacology and he has given many lectures and speeches on these topics, including keynote lectures.
Ralph Mösges is the author and editor of 7 books and has published more than 150 articles in prominent journals. He holds several editorial positions for such journals.
He serves as a member of the guidelines committee of the German Academy of Otorhinolaryngology, Head and Neck Surgery and is a member of their task forces for the development of guidelines in sensorineural hearing loss and in rhinosinusitis.
 

Professor Oliver Pfaar

Oliver Pfaar 2131d
Oliver Pfaar is Head of the Section Rhinology and Allergy, ORL-Department at University Hospital Marburg, Germany. As both otorhinolaryngologist and allergist, his clinical and scientific work has primarily focused on diseases of the upper airways such as allergic rhinoconjunctivitis, chronic rhinosinustitis and smell&taste. He has published more than 200 scientific articles in this field, and he has also been involved as coordinating and/or principal investigator in designing and performing more than 50 international clinical trials mainly in the area of allergen immunotherapy (AIT). Pfaar has been leading and corresponding author of multiple guidelines in the field of allergic diseases such as the recently published guideline of the European Academy of Allergy and Clinical Immunology (EAACI) on ‘AIT in allergic rhinoconjunctivitis‘. Besides Prof. Pfaar is member of the EAACI Executive Committee and of the board of directors of the German Society of Allergy and Clinical Immunology (DGAKI).